This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. drocimigenol-3-O-[2′-O-acetyl]-β-D-xylopyranoside (20) [24], 23-epi-26-deoxyactein (21) [25], actein (22) [26], 24-O-acetyl-7 (8)-en-hydroshengmanol (23) [27], 24-O-acetylisodahurinol-3-O-[2′-O-acetyl]-α-L-arabinopyranoside (24) [25], 23-O-acetylshengmanol-3-O-β-D-xylopyranoside (25) [28], and cimiracemonol B (26) [29] , were isolated and identified (l " Fig. 1 ). The isolated compounds were evaluated for their cytotoxicities against human HL-60, SMMC-7721, A549, MCF-7, and SW480 cell lines, using the MTT method. Described herein are the isolation, structure elucidation, and biological activities of the compounds.
Introduction ! Cancer has become one of the major causes of mortality in humans throughout the world. In 2007, 7.6 million people died from cancer. Significantly, 27 million new cancer cases and 17.5 million cancer deaths are projected to occur in the world by 2050 [1] . Natural products have been a rich source of antitumor agents, and approximately 60% of currently available drugs are natural compounds or are related to them (from 1940 to 2010) [2] . As one of the three ancient medicinal systems, traditional Chinese medicine (TCM), has gained increasing acceptance and has been recognized by pharmaceutical enterprises as a fountainhead of antitumor drugs [3] . According to the theories of TCM, cancer is caused by imbalances between endogenous physical conditions of the body and exogenous pathogenic factors, including accumulated toxins, heat, and blood stasis [3] . Therefore, the roots of Cimicifuga foetida, belonging to the family Ranunculaceae and officially listed in the Chinese Pharmacopoeia with the name "shengma" as a cooling and detoxicating agent [4] , were chosen as the object to investigate potential antitumor constituents. As a result, a number of cytotoxic 9,19-cycloartane triterpenes were succes-sively isolated from this herb medicine [5] [6] [7] . In addition, the preliminary structure-activity relationships (SAR) of the triterpenes with a cimigenol skeleton were proposed [8] . In the Chinese Pharmacopoeia, the roots of C. dahurica are another element of "shengma" [4] . Chemical studies on C. dahurica showed that it also mainly contains 9,19-cyclolanostane triterpenes [9] [10] [11] [12] [13] [14] [15] [16] . Recently, other research groups paid attention to chemical and pharmaceutical properties of the aerial parts of C. dahurica and reported that the ethyl acetate fraction of an 80 % ethanol extract and three isolated cycloartane triterpenoids displayed growth inhibitory activities against several human tumor cell lines [17, 18] . However, little is known about the cytotoxic triterpenes of the roots of C. dahurica [19] . Inspired by the described observations concerning C. foetida, we undertook phytochemical and pharmacological investigations on the roots of C. dahurica. Twelve new 9,19-cyclolanostane triterpenes (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) , together with fourteen known compounds, cimigenol (13) [20] , 7(8)-en-cimigenol (14) [21] , 25-O-acetyl-7(8)-en-cimigenol (15) [21] , cimigenol-3-one (16) [22] , 24-epi-cimigenol-7(8)-en-3-one (17) [21] , cimigenol-1(2)-en-3-one (18) [ (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) , together with fourteen known compounds (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) , were isolated from the roots of Cimicifuga dahurica. Their structures were determined by application of spectroscopic analyses and chemical methods. Biological evaluation of the compounds against human HL-60, SMMC-7721, A549, MCF-7, and SW-480 cell lines indicated that cimigenoltype glycosides (1) (2) (3) 19 , and 20) showed broadspectrum and moderate cytotoxicities, with IC 50 values ranging from 4.2 to 14.5 µM. Meanwhile, cimigenol-type aglycones (6-8, 15, 16, and 18) exhibited broad-spectrum and week cytotoxicities, having IC 50 values around 20 µM. In addition, the key points of the structure-activity relationships of aglycones with a cimigenol skeleton were discussed. 
Plant material

Extraction and isolation
The dried and milled roots of Cimicifuga dahurica (0.9 kg) were extracted with MeOH (3 × 3 L × 24 h) at room temperature to give a residue (106 g) after evaporating in vacuum at 50°C. The extract was subjected to silica gel cc (2 kg, 10 × 150 cm) and eluted with CHCl 3 -MeOH [100 : 0 (2 L), 50 : 1 (4 L), 20 : 1 (5 L), 10 : 1 (4 L), 0 : 100 (3 L)] to afford fractions A (21.5 g), B (13.1 g), C (14.5 g), D (16.8 g), and E (16.2 g). Fraction B (13.1 g) was divided into five sub-fractions (B.1-B.5) after performing RP-18 cc (180 g, 5 × 25 cm), eluting with MeOH-H 2 O (gradient from 60 : 40 to 100 : 0, 10 L). Fraction B.3 (1.5 g) was subjected to repeated silica gel cc (40 g, 4 × 40 cm) eluted with CHCl 3 -Me 2 CO (gradient from 20 : 1 to 10 : 1, 4 L) and then to repeated semipreparative HPLC (eluted with CH 3 CN-H 2 O, gradient from 60 : 40 to 85 : 15) to yield 4 (3.0 mg), 5 (3.0 mg), 6 (2.0 mg), 13 (4.0 mg), 16 (4.7 mg), and 26 (3.6 mg). Compounds 7 (2.8 mg), 14 (3.2 mg), 15 (3.5 mg), 17 (2.3 mg), 18 (2.5 mg), and 23 (2.2 mg) were purified from fraction B.4 (1.8 g) by silica gel cc (30 g, 3.5 × 40 cm) eluted with CHCl 3 -Me 2 CO (20 : 1, 3 L), followed by repeated semipreparative HPLC (eluted with CH 3 CN-H 2 O, gradient from 65 : 35 to 85 : 15). Fraction B.5 (0.9 g) was applied to a silica gel column (30 g, 3.5 × 40 cm) eluted with CHCl 3 -Me 2 CO (20 : 1, 3 L), then purified over semipreparative HPLC (eluted with CH 3 CN-H 2 O, gradient from 65 : 35 to 90 : 10) to afford 8 (2.7 mg), 9 (1.2 mg), 10 (1.9 mg), and 11 (1.6 mg). Fraction C (14.5 g) was fractionated into four subfractions (C.1-C.4) by performing RP-18 cc (180 g, 5 × 25 cm) eluted with MeOH-H 2 O (gradient from 60 : 40 to 90 : 10, 12 L). Fraction C.3 (2.8 g) was subjected to silica gel cc (50 g, 4 × 40 cm) eluted with CHCl 3 -Me 2 CO (gradient from 10 : 1 to 5 : 1, 4 L), then to repeated semipreparative HPLC (eluted with CH 3 CN-H 2 O, gradient from 60 : 40 to 75 : 25) to give 1 (5.5 mg), 2 (4.8 mg), 3 (4.3 mg), 12 (5.3 mg), 19 (3.3 mg), and 24 (28 mg). Fractions C.1 and C.2 (4.8 g) were chromatographed on silica gel cc (50 g, 4 × 40 cm), eluting with CHCl 3 -Me 2 CO (10 : 1, 8 L) to yield 20 (5.2 mg), 21 (6.0 mg), 22 (5.2 mg), and 25 (4.2 mg). Hydrolysis and identification of the sugar moieties in compounds 1, 2, 3, and 12
Compound 1 (4.0 mg) together with 2 and 3 (3.0 mg of each) were individually dissolved in MeOH (5 mL), then 4 % K 2 CO 3 (5 mL) was added, and each solution was stirred at rt overnight. Each solution was neutralized by 10% HOAc and extracted with EtOAc (3 × 15 mL). Each EtOAc extract, after removal of solvent, was dissolved in MeOH (5 mL) and refluxed with 0.5 N HCl (3 mL) for 4 h [7] . Compound 12 (4.0 mg), by contrast, was directly dissolved in MeOH (5 mL) and refluxed with 0.5 N HCl (3 mL) for 4 h. Each reaction mixture was diluted with H 2 O and extracted with CHCl 3 (3 × 10 mL). Each aqueous layer was then neutralized by Ag 2 CO 3 , and the formed precipitation was filtered to give a monosaccharide, which had an Rf (2-5, 7, 8, 10, 11) and 150 MHz (1, 6, 9, 12 
q
Cytotoxicity bioassay
Five human cancer cell lines, human myeloid leukemia HL-60, hepatocellular carcinoma SMMC-7721, lung cancer A-549, breast cancer MCF-7, and colon cancer SW480, were used in the cytotoxic assay. Cells were cultured in DMEM medium (Hyclone) supplemented with 10 % fetal bovine serum (Hyclone), in 5% CO 2 at 37°C. The cytotoxicity assay was performed according to the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] method in 96-well microplates [32, 33] . Briefly, 100 µL of adherent cells were seeded into each well of 96-well cell culture plates and allowed to adhere for 12 h before addition of test compounds, while suspended cells were seeded just before drug addition with an initial density of 1 × 10 5 cells/mL. Each tumor cell line was exposed to the test compounds (dissolved in DMSO, then diluted by DMEM medium) at concentrations of 0.064, 0.32, 1.6, 8, and 40 µM in triplicate for 48 h, with cisplatin (Sigma) and culture solution as positive and negative controls, respectively. After compound treatment, cell viability was detected, and a cell growth curve was graphed. IC 50 values were calculated by Reed and Muenchʼs method [34] .
Supporting information
The NMR spectra of compounds 1-12, as well as ESI and HR-TO-F-ESI data of 1-12 are available as Supporting Information. [15] showed that, structurally, 1 closely resembles 27, with the main differences of the sugar unit and the presence of another tetra-carbon unit, including the α,β-unsaturated ketone resonances. In the 1 H-1 H COSY spectrum (l " Fig. 2) , a correlation was observed between the secondary methyl signal at δ H 1.63 (d, J = 6.5 Hz) and the olefinic proton at δ H 7.09 (m), which indicated the tetra-carbon unit to be a 2-butenoyl. In addition, the coupling constant (J = 15.6 Hz) of the two olefinic protons at δ H 6.05 and 7.09 confirmed the E-geometry of a double bond in the 2-butenoyl moiety. In the HMBC spectrum (l " Fig. 2) , a correlation was observed between the anomeric proton at δ H 4.79 (H-1′, 1H, d, J = 7.5 Hz) and the methine signal at δ C 89.2 (C-3), suggesting that a sugar unit was attached at the C-3. The sugar obtained after acid hydrolysis was identified as α-Larabinose by comparing its TLC and specific rotation with the standard. In the 1 H NMR spectrum, a downfield resonance was observed at δ H 5.99 (t, J = 8.5 Hz), which showed correlations with the methine resonance at δ H 4.30 (H-3′) and the anomeric proton at δ H 4.79 in the 1 H-1 H COSY spectrum (l " Fig. 2) . Furthermore, the HMBC (l " Fig. 2 ) correlation between the carbonyl group (δ C 166.3) and the proton resonance (δ H 5.99, t, J = 8.5 Hz) indicated the (E)-2-butenoyl unit was attached at C-2′. In the ROESY spectrum (l " Fig. 3 ), H-3 showed a correlation with H-5 suggesting an α-orientation of the H-3, while H-15 showed a correlation with Me-18, indicating an α-orientation of the hydroxyl group at C-15. The configuration of C-23 and C-24 was deduced as R and S, respectively, by comparison of the coupling constant of H-23 and H-24 with those of cimigenol-type compounds [6, 22, 26] . Therefore, the structure of 1 was determined as cimigenol (19) , except for the sugar moiety. In the 1 H-NMR spectrum (l " Table 1) of 2, the signal due to H-4′ showed a downfield shift from δ H 4.16 to 5.50. Meanwhile, the signal of H-2′ was shifted from δ H 5.89 to δ H 4.38. In addition, the signal due to C-4′ exhibited a downfield shift from δ C 69.8 to 72.3 in the 13 C NMR spectrum (l " Table 2 ). The changes of these chemical shifts may be explained by the Oacetyl group being attached to C-4 of the sugar unit, which was further confirmed by the presence of the HMBC correlation between the H-4′ signal at δ H 5.50 and the carbonyl group signal at δ C 170.8. The sugar obtained after acid hydrolysis was confirmed as α-L-arabinopyranose by comparing its TLC and specific rotation with the standard. The configurations of C-23 and C-24 are proposed as R and S, respectively, by the same way as that of 1. Thus, the structure of 2 was assigned as 25-O-acetylcimigenol-3-O-[4′-O-acetyl]-α-L-arabinopyranoside. In the same way, an acetoxy group was determined to be at C-3′ for 3, which was further confirmed by the presence of the HMBC correlation between the H-3′ signal at δ H 5.48 and the carbonyl group signal at δ C 170.8. Therefore (14) . The 1 H NMR spectrum (l " Table 1 ) displayed downfield cyclopropane methylene signals at δ H 0.73 (1H, d, J = 4.0 Hz) and 1.19 (overlapped), seven methyl groups at δ H 1.07-1.52, and an olefinic proton at δ H 6.20 (1H, d, J = 7.0 Hz), respectively, suggesting 4 to be a 9,19-cyclolanostane aglycone with a pair of olefinic carbons close to the cyclopropane methylene at C-19 [20] . The NMR data of 4 showed a close resemblance with those of 14, except that the methylene signal at δ C 33.7 (C-12) was absent, showing instead a hydroxymethine at δ C 72.5. On the basis of the above observations, it was reasonable to deduce that 4 was a 12-hydroxy derivative of 14, which was also supported by the HMBC correlations of H-12 at δ H 4.36 with C-11 (δ C 40.3), C-13 (δ C 47.1), and CH 3 -18 (δ C 13.2), as well as by the downfield shift of C-11 about 14.9 ppm in the 13 C spectrum (l " Table 2 ). Significant ROESY correlations of H-12 with H-5, and CH 3 -28 suggested a β-orientation of the substituent at C-12. Therefore, 4 was elucidated as 12β-hydroxy-7(8)-en-cimigenol. Compound 5 was assigned as C 30 H 46 O 6 , as deduced from the HR-TOF-ESIMS (m/z 525.3199 [M + Na] + ), which is identical to that of compound 4. The NMR data of 5 were similar to that of 4 with the major difference being that a hydroxyl group was shifted from C-12 to C-11. In the 13 C NMR spectrum (l " Table 2) of 5, the signal due to C-12 exhibited an upfield shift from δ C 72.5 to 49.4, while C-11 showed a downfield shift from δ C 40.3 to 63.5, further confirming the deduction. The relative configuration of the hydroxyl group at C-11 was proposed as β-orientated by analyses of the ROESY spectrum. Accordingly, compound 5 was characterized as 11β-hydroxy-7(8)-en-cimigenol. Compound 6 had the molecular formula C 30 H 44 O 5 from its positive mode HR-TOF-ESIMS (507.3090 [M + Na] + ). In the 13 C and DEPT spectra (l " Table 2), 6 exhibited signals very similar to those of 5 except that hydroxy methine signals due to C-3 and C-15 were absent, whereas a carbonyl carbon at δ C 216.1 and a downfield methylene at δ C 45.8 were observed. In addition, HMBC correlations of H-2, CH 3 -29, and CH 3 -30 with the carbonyl group at δ C 216.1 and protons (δ H 2.46 and 2.28, each 1H) due to the methylene at δ C 45.8 with C-14, C-16, and CH 3 -28 indicated that a carbonyl carbon replaced a hydroxyl group at C-3, and the methine at C-15 was transformed to a methylene in 6. Ultimately, 6 was elucidated as 11β-hydroxy-15-deoxycimigenol-7(8)-en-3-one. The HR-TOF-ESIMS (m/z 507.3086 [M + Na] + ) of compound 7 determined its molecular formula as C 30 H 44 O 5 , which is identical with 24-epi-cimigenol-7(8)-en-3-one (17) . The NMR data (l " Tables 1 and 2) of 7 resembled those of 17 with major differences at C-22 (δ C 38.0), C-23 (δ C 72.1), C-24 (δ C 90.3), and C-25 (δ C 70.9), which are similar to the key structural differences between cimigenol-type and 24-epi-cimigenol-type triterpenes [21] . By comparing the coupling constant of H-24 (0 Hz) with those of cimigenol-type compounds (0 Hz) and 24-epi-cimigenol-type constituents (4 Hz), the configuration of C-24 of 7 was determined to be S [6, 21, 25] . Thus, 7 was elucidated as cimigenol-7(8)-en-3one. The molecular formula of compound 8 was determined as C 30 H 42 O 5 from the HR-TOF-ESIMS (m/z 505.2944 [M + Na] + ). Its NMR data (l " Tables 1 and 2) were similar to those of 7 except for the signals of ring A. Unsaturated carbon signals at δ C 152.6 and 127.2 were observed in 8, whereas signals of two methylenes due to C-1 and C-2 were absent. Significant HMBC correlations were observed between the carbonyl C-atom at δ C 203.8 and the olefinic protons at δ H 6.16 and 6.71 (each 1H, d, J = 10.0 Hz). The above evidence suggested that compound 8 is transformed from 7 through dehydrogenation between C-1 and C-2. Therefore, compound 8 was characterized as cimigenol-1(2),7(8)-dien-3one. Compound 9 was assigned a molecular formula of C 30 H 46 O 4 from its HR-TOF-ESIMS (m/z 469.3311 [M + H] + ). In the 1 H NMR spectrum, signals for the significant downfield cyclopropane methylene at δ H 3.15 and 3.24 (1H each, d, J = 14.0 Hz), seven methyl groups at δ H 0.81-1.52, and three olefinic protons at δ H 5.39, 5.52, and 5.54 were observed, suggesting 9 is a 9,10-seco-9,19cycloartane triterpene [30] . The 13 C NMR and DEPT spectroscopic data of 9 were identical with the aglycone resonances of cimicinol (28) [31] , except for the upfield shift of the C-3 by 9.7 ppm, which could be explained by the absence of a sugar unit at C-3. Therefore, 9 was elucidated as 9,10-seco-1(10),7(8),9(11)-triencimigenol. The molecular formula of compound 10 was established as C 32 H 50 O 6 on the basis of HR-TOF-ESIMS (m/z 553.3494 [M + Na] + ). In the IR spectrum, absorption bands at 3473 and 1733 cm −1 for hydroxyl and carbonyl groups were observed. In the 13 C and DEPT NMR spectra, the signals ascribable to the methylene carbon of the cyclopropane ring at δ C 31.3 (C-19), four oxygen-bearing methine carbons at δ C 84.3 (C-16), 79.8 (C-24), 79.1 (C-23), and 77.9 (C-3), as well as two carbonyl carbons at δ C 213.9 (C-15) and 171.1 (C 24 -acetoxy) were observed, suggesting that 10 was a highly oxygenated 9,19-cycloartane triterpene aglycon with an O-acetyl group. By comparison of NMR spectroscopic data, 10 was determined to be the aglycon of 24-O-acetylisodahurinol-3-O-α-L-arabinopyranoside (29) [7] . The configuration of C-24 was deduced as S by comparison of the coupling constants of H-24 (1.6 Hz) with those of dahurinyl diacetate (9 Hz) and isodahurinyl diacetate (2 Hz) [29] . Accordingly, compound 10 was characterized as 24-O-acetylisodahurinol. Compound 11 gave a molecular formula of C 32 [27] , which may be due to an acetyl group. When its spectroscopic data (l " Tables 1 and 2) were compared with those of 30 [27] , an additional O-acetyl group was assigned to C-15 on the basis of the upfield shift of the carbonyl carbon (C-16) from δ C 220.3 to 214.2, the downfield shift of H-15 from δ H 4.56 to 5.92, as well as the HMBC correlation of H-15 and the carbonyl group signal at δ C 170.9. Significant ROESY correlations of H-15 with CH 3 -18 sug-gested an α-orientation of the substituent at C-15. The configurations of C-23 and C-24 were considered to be R and S, respectively, by comparing coupling constants of H-23 and H-24 with those of known 9,19-cyclolanostane triterpene glycosides [25] . In the 13 C NMR spectrum (l " Table 2), compound 12 showed resonances corresponding to an α-L-arabinose moiety at δ C 108.1 (d), 73.4 (d), 75.2 (d), 70.2 (d), and 66.5 (t) [8, 29] , which was further confirmed by comparing its TLC and specific rotation with the standard after hydrolysis. Ultimately, 12 was elucidated as 15,23-Odiacetyl-7(8)-en-shengmanol-3-O-α-L-arabinopyranoside. All isolated compounds were screened for their in vitro antitumor activities. As summarized in l " Table 3 , the new compounds 1-3 and the known compounds 19 and 20 showed broad-spectrum and moderate cytotoxicities against human HL-60, SMMC-7721, A549, MCF-7, and SW480 cell lines, with IC 50 values ranging from 4.2 to 14.5 µM. In addition, the new compounds 6-8 and the known compounds 15, 16, and 18 exhibited broad-spectrum and week cytotoxicities, having IC 50 values around 20 µM. Based on the above results, we suggest that the roots of C. dahurica may be another potential resource for promising antitumor agents. In the present study, structural and bioactive properties of five cimigenol-type glycosides (1-3, 19, 20) are completely in accordance with the SAR we proposed before. Thus, the SAR proposed in our previous studies may be used for the design of more potent lead compounds. Furthermore, six cimigenol-type aglycons (6-8, 15, 16, 18) exhibited broad-spectrum and week cytotoxicities. The main structural characters of these compounds are: (1) the configurations of C-23 and C-24 are R and S, respectively; (2) carbonyl and acetoxy groups instead of a hydroxyl group at C-3 or C-25. Previously, we reported that cimigenol-type aglycone actrin-3-one has potent and moderate activities against human HepG-2 and HT 29 cell lines, respectively. Meanwhile, 25-O-acetylcimigenol exhibited moderate activity against the human HepG-2 cell line [7] . Based on the analyses of these data, we may propose that for cimigenol-type aglycones, hydrophobic groups, such as carbonyl and acetoxy, instead of a hydroxyl group at C-3 or C-25 are essential for cytotoxicity. 
Results and Discussion
